Anti-GPNMB Antibody (Glembatumumab)
Catalog No.
F1701
Anti-GPNMB Antibody (Glembatumumab)
Featured Products
Glembatumumab is a fully human IgG2 monoclonal antibody directed against the extracellular domain of GPNMB expressed in human breast cancer and melanoma. Glembatumumab can be conjugated with the microtubule inhibitor monomethyl auristatin E to form Glembatumumab vedotin. Glembatumumab vedotin is an antibody-active molecule conjugate (ADC) with anti-tumor activity.
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145 kDa
Dry ice
1020264-78-1
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
CR011
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q14956
Human
Unconjugated
Monoclonal
Protein A
IgG2SA
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human GPNMB his at 2 ug/mL can bind Anti-GPNMB Antibody (Glembatumumab)
GPNMB
Please avoid freeze-thaw cycles.